Cargando…
Advances in clinical chemistry. Volume 30 /
ADVANCES IN CLINICAL CHEMISTRY VOL 30.
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
San Diego :
Academic Press,
�1993.
|
| Colección: | Advances in clinical chemistry ;
v. 30 |
| Temas: | |
| Acceso en línea: | Texto completo Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn298084639 | ||
| 003 | OCoLC | ||
| 005 | 20231117015158.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 090111s1993 caua ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e pn |c N$T |d OCLCQ |d UBY |d IDEBK |d E7B |d OCLCQ |d OPELS |d OCLCQ |d OCLCF |d OCLCQ |d DEBSZ |d LEAUB |d S2H |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO | ||
| 019 | |a 505068865 |a 646759154 | ||
| 020 | |a 9780080566283 |q (electronic bk.) | ||
| 020 | |a 0080566286 |q (electronic bk.) | ||
| 020 | |a 0120103303 |q (electronic bk.) | ||
| 020 | |a 9780120103300 |q (electronic bk.) | ||
| 035 | |a (OCoLC)298084639 |z (OCoLC)505068865 |z (OCoLC)646759154 | ||
| 050 | 4 | |a RB40 |b .A38eb vol. 30 | |
| 072 | 7 | |a SCI |x 013020 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.07/56 |2 22 |
| 245 | 0 | 0 | |a Advances in clinical chemistry. |n Volume 30 / |c edited by Herbert E. Spiegel. |
| 260 | |a San Diego : |b Academic Press, |c �1993. | ||
| 300 | |a 1 online resource (ix, 389 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 0 | |a Advances in clinical chemistry ; |v v. 30 | |
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a Front Cover -- Advances in Clinical Chemistry, Volume 30 -- Copyright Page -- Contents -- Contributors -- Preface -- Chapter 1. The Cytokines: Physiological and Pathophysiological Aspects -- 1. Introduction -- 2. Biochemistry -- 3. Pathophysiology -- 4. Cytokine Measurements in Disease -- 5. Cytokine Assays in Body Fluids -- References -- Chapter 2. Analytical Applications of Chemiluminescence -- 1. Introduction and Scope of the Article -- 2. Theoretical Background -- 3. Applications of Specific Chemiluminescent Compounds -- 4. Conclusion -- References. | |
| 505 | 8 | |a 12. ERP/PRP Content in Sequential Breast Biopsies -- 13. ERP in Visceral Metastases -- 14. Correlation with Epidemiology and Pathology -- 15. ERP in Male Breast Cancer -- 16. Role of ERP/PRP in Patients with Melanomas, Thyroid Cancer, or Prostate Cancer -- References -- Chapter 4. Advances in Human leukocyte Antigens and Transplantation -- 1. Transplantation in Historical Perspective -- 2. The Human Leukocyte Antigen System -- 3. HLA and the Immune Response -- 4. The Immunological Basis of Transplant Rejection -- 5. HLA and Renal Transplantation. | |
| 505 | 8 | |a 6. HLA and Bone Marrow Transplantation -- 7. Transplantation of Other Organs -- 8. Future Developments in HLA and Transplantation -- References -- Chapter 5. Glutathlone S-Transferases: Biomedical Applications -- 1. Introduction -- 2. The Multiple Activities and Pseudonyms of GST -- 3. Historical Perspective -- 4. Properties of Glutathione S-Transferases -- 5. Glutathione S-Transferase Isoenzymes -- 6. Biomedical Applications of GST -- 7. The Quantitation of GST in Biological Fluids -- 8. Developmental Expression of GST in Human Tissues. | |
| 505 | 8 | |a 9. Plasma Alpha-Class GST Measurements in Liver Disease -- 10. GST Measurements in Malignancy -- 11. The Glutathione S-Transferases and the Kidney -- 12. Conclusions -- References -- Index. | |
| 505 | 8 | |a Chapter 3. Estrogen and Progesterone Receptor Proteins In Patients with Breast Cancer -- 1. Introduction -- 2. Mechanism of Action -- 3. Prediction and Prognostic Usefulness of ERP/PRP -- 4. Nuclear ERP versus Cytosolic ERP/PRP Prognostic Values -- 5. Hormonal Therapy versus ERP/PRP Status -- 6. Role of ERP/PRP in TAM Therapy -- 7. Chemotherapy versus ERP/PRP Status -- 8. Radiation Therapy versus ERP Status -- 9. Fine Needle Aspiration Impact on Receptor Analysis -- 10. Role of ERP/PRP in �-Interferon Therapy -- 11. Measurements of Receptors. | |
| 520 | |a ADVANCES IN CLINICAL CHEMISTRY VOL 30. | ||
| 650 | 0 | |a Clinical chemistry. | |
| 650 | 2 | |a Chemistry, Clinical |0 (DNLM)D002624 | |
| 650 | 6 | |a Chimie clinique. |0 (CaQQLa)201-0016714 | |
| 650 | 7 | |a SCIENCE |x Chemistry |x Clinical. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a Clinical chemistry |2 fast |0 (OCoLC)fst00864330 | |
| 700 | 1 | |a Spiegel, Herbert E. | |
| 776 | 0 | 8 | |i Print version: |t Advances in clinical chemistry. Volume 30. |d San Diego : Academic Press, �1993 |z 9780120103300 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780120103300 |z Texto completo |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/bookseries/00652423/30 |z Texto completo |